Singular Genomics Systems Inc’s filing revealed that its Chief Executive Officer Spaventa Andrew acquired Company’s shares for reported $31755.0 on Nov 17 ’23. In the deal valued at $0.42 per share,75,000 shares were bought. As a result of this transaction, Spaventa Andrew now holds 4,061,206 shares worth roughly $1.75 million.
Then, Glezer Eli N. bought 200,000 shares, generating $85,640 in total proceeds. Upon buying the shares at $0.43, the Chief Scientific Officer now owns 4,570,000 shares.
Before that, Spaventa Andrew bought 43,468 shares. Singular Genomics Systems Inc shares valued at $17,857 were divested by the Chief Executive Officer at a price of $0.41 per share. As a result of the transaction, Spaventa Andrew now holds 3,986,206 shares, worth roughly $1.71 million.
UBS downgraded its Singular Genomics Systems Inc [OMIC] rating to a Neutral from a a Buy in a research note published on August 17, 2022; the price target was decreased to $4.50 from $10. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in early August from “a Buy” to “a Neutral”. BofA Securities also remained covering OMIC and has decreased its forecast on August 10, 2022 with a “an Underperform” recommendation from previously “Buy” rating. BofA Securities revised its rating on January 07, 2022. It rated OMIC as “a Buy” which previously was an “a Neutral”.
Price Performance Review of OMIC
On Monday, Singular Genomics Systems Inc [NASDAQ:OMIC] saw its stock jump 4.58% to $0.43. Over the last five days, the stock has gained 8.68%. Singular Genomics Systems Inc shares have fallen nearly -6.11% since the year began. Nevertheless, the stocks have fallen -59.25% over the past one year. While a 52-week high of $1.21 was reached on 02/27/24, a 52-week low of $0.31 was recorded on 04/11/24. SMA at 50 days reached $0.4808, while 200 days put it at $0.4723. A total of 0.74 million shares were traded, compared to the trading of 0.18 million shares in the previous session.
Levels Of Support And Resistance For OMIC Stock
The 24-hour chart illustrates a support level at 0.3881, which if violated will result in even more drops to 0.3443. On the upside, there is a resistance level at 0.4979. A further resistance level may holdings at 0.5639. The Relative Strength Index (RSI) on the 14-day chart is 50.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0108, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 61.11%. Stochastics %K at 48.69% indicates the stock is a holding.
